يرجى استخدام متصفح الكمبيوتر الشخصي للوصول إلى التسجيل - تداول السعودية
حسنًا
Canaccord Genuity Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $105
Rhythm Pharmaceuticals -0.06%
Rhythm Pharmaceuticals RYTM | 112.45 | -0.06% |
Canaccord Genuity analyst Whitney Ijem maintains Rhythm Pharmaceuticals (NASDAQ:
RYTM) with a Buy and raises the price target from $92 to $105.
